To distinguish between Stages I + II and Stages III + IV of ovarian cancer the most perspective set would include LOC285205, CGGBP1, EPHB1, and NKIRAS1/RPL15 biomarkers. This evidence concerns the gene RPL15 and ovarian cancer.